CIRM gives industry just $30m from $3bn stem cell research funds
This article was originally published in Scrip
Executive Summary
The California Institute for Regenerative Medicine (CIRM) answered the biotechnology industry's request for a bigger slice of the state's $3 billion stem cell research funding pie with a $30 million grant program that will give up to $10 million each to three development programmes that can complete a clinical trial in patients within the next four years. That may not be enough for some in the industry.